Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131017/ http://dx.doi.org/10.1016/0264-410X(92)90122-Z |
_version_ | 1783517141760212992 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7131017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1992 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71310172020-04-08 Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses Vaccine Patent Report Published by Elsevier Ltd. 1992 2002-11-13 /pmc/articles/PMC7131017/ http://dx.doi.org/10.1016/0264-410X(92)90122-Z Text en © 1992 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Patent Report Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
title | Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
title_full | Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
title_fullStr | Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
title_full_unstemmed | Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
title_short | Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
title_sort | vaccine comprising live attenuated or inactivated rotavirus strains; hrv 89-12c2, hrv 408, hrv 248 hrv 456 and/or cjn, for immunization against rotavirus illnesses |
topic | Patent Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131017/ http://dx.doi.org/10.1016/0264-410X(92)90122-Z |